BioCentury
ARTICLE | Clinical News

Metra regulatory update

September 5, 1995 7:00 AM UTC

The FDA approved MTRA's Alkphase-B assay for aiding the management of patients with Paget's disease of bone. Alkphase-B measures serum levels of bone-specific alkaline phosphatase (BAP), an enzyme released into the bloodstream as a result of bone formation. ...